FRONT GENET 润色咨询

Frontiers in Genetics

出版年份:暂无数据 年文章数:9811 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2024-01-04 ms3000000029380120 来自江苏省

    审稿速度:2.0
    经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中.......

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2023-07-01 287119938 来自贵州省

    审稿速度:6.0
    经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2023-06-16 ms9000001727788658 来自北京

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:点突变
    经验分享:麻烦问下,从接收到正式发表,需要多长时间呀

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2022-09-01 ms8000000941284145

    偏重的研究方向:肿瘤;基因;生信
    经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。

    20

    展开20条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2022-11-12 ms9000000913432311

    偏重的研究方向:纯生信;生信;生物信息
    经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2021-05-19 哈哈小猪

    第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?

    10

    展开10条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2023-03-12 董柏 来自浙江省

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享:4个审稿人,纯生信文章,2个半月

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2022-10-31 ms2000001036693367

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。
    2022.8.31 投稿
    2022.9.9 送审
    2022.9.14 第一个审稿人初审结束(小修)
    2022.9.28 第二个审稿人初审结束(大修)
    2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件
    2022.10.14 提交修改后的手稿
    2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)
    2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)
    两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天
    2022.10.27 进入final validation 阶段
    2022.10.29 接收
    总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。

    7

    展开7条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2023-11-07 海边的雪儿 来自山东省

    偏重的研究方向:肿瘤免疫
    经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final.
    这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦,已经accepted for publication了,而且版面费都交了,结果突然来了一封信说拒稿退钱,这是什么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:4个审稿人,纯生信文章,2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097565, encodeId=f1eb209e5654c, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投了一篇纯生信的文章,今年研三了,刚好完成了自己的毕业指标。总体来说是属于比较幸运的类型。从投稿到接收快两个月,下面分享一下自己的时间线希望对大家有所帮助。<br>2022.8.31 投稿<br>2022.9.9 送审<br>2022.9.14 第一个审稿人初审结束(小修)<br>2022.9.28 第二个审稿人初审结束(大修)<br>2022.10.1 交互评审开放,给了半个月时间修改,提示截止2022.10.15提交自己修改后的稿件<br>2022.10.14 提交修改后的手稿<br>2022.10.15 第一个审稿人二审结束,finalized (endorsed the publication)<br>2022.10.19 第二个审稿人二审结束,finalized (没看到是什么意见,但是根据第一个推测也是endorsed)<br>两个审稿人都结束以后直接就进入了review finalized 阶段,这个过程持续了9天<br>2022.10.27 进入final validation 阶段<br>2022.10.29 接收 <br>总体来说很快,我感觉整个投稿过程除了第二个审稿人在一审的时候花费了比较久的时间,其他的都很给力。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6be8230020, createdName=ms2000001036693367, createdTime=Mon Oct 31 10:26:01 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167189, encodeId=aba8216e1895d, content=偏重的研究方向:肿瘤免疫<br>经验分享:投了一篇,秒拒。理由:This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies”This decision applies across all Frontiers journals and is final. <br>这到底是啥情况啊?发邮件问原因,也不回复。而且还说这个决定适用于frontiers系列所有期刊。我们的研究都有原始数据。这到底是是为啥呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6351657413, createdName=海边的雪儿, createdTime=Tue Nov 07 10:50:39 CST 2023, time=2023-11-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167225, encodeId=3c0f216e22511, content=请问肿瘤纯生信还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96c15321357, createdName=148ac126m95暂无昵称, createdTime=Tue Nov 07 14:52:16 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省)]
    2023-11-07 148ac126m95暂无昵称 来自浙江省

    请问肿瘤纯生信还收吗?

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分